| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2007 | EP1778205A1 Hydrating composition |
| 05/02/2007 | EP1778204A2 Compositions and methods relating to novel compounds and traget thereof |
| 05/02/2007 | EP1778202A1 Use of vitamin d receptor activators or vitamin d analogs to treat cardiovascular disease |
| 05/02/2007 | EP1778201A2 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 05/02/2007 | EP1778195A2 Anti-histaminic composition |
| 05/02/2007 | EP1778193A2 Sustained release pharmaceutical particulate composition comprising venlafaxine |
| 05/02/2007 | EP1778190A1 Modafinil oral lyophilizate |
| 05/02/2007 | EP1778186A1 Method for preparation of poly-iclc and uses thereof |
| 05/02/2007 | EP1778185A1 Pressurized foaming composition for topical treatment of psoriasis |
| 05/02/2007 | EP1778183A1 Liquid paroxetine compositions |
| 05/02/2007 | EP1778082A1 Carboranylporphyrins and uses thereof |
| 05/02/2007 | EP1701958B1 Pyrrolo-pyrazine derivatives useful as cb1-modulators |
| 05/02/2007 | EP1644014B1 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions |
| 05/02/2007 | EP1641787B1 Substituted diketopiperazines and their use as oxytocyn antagonists |
| 05/02/2007 | EP1635838B1 Phosphodiesterase-5-inhibitors for the prophylaxis and/or treatment of portal hypertension |
| 05/02/2007 | EP1628639A4 Antimicrobial quaternary ammonium organosilane coatings |
| 05/02/2007 | EP1608645B1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 05/02/2007 | EP1605952B1 Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs |
| 05/02/2007 | EP1592694B1 Active ingredient particles with clopidogrel or a pharmaceutically acceptable salt thereof |
| 05/02/2007 | EP1576160B1 Borrelidin-derivatives and their use in medicine |
| 05/02/2007 | EP1575942B1 compounds having selective inhibiting efect at gsk3 |
| 05/02/2007 | EP1567133B1 Pharmaceutical antiviral compositions |
| 05/02/2007 | EP1552834B1 N-acetyl-l-pipecolic acid as neurotrophic factor production promoter |
| 05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 05/02/2007 | EP1546134B1 Piperazine substituted aryl benzodiazepines |
| 05/02/2007 | EP1526870B1 Combination of loteprednoletabonat and dfho for treating respiratory diseases, allergic diseases, asthma and copd |
| 05/02/2007 | EP1501521B1 Long acting compositions comprising zidovudine and/or lamivudine |
| 05/02/2007 | EP1501517B1 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
| 05/02/2007 | EP1499589B1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
| 05/02/2007 | EP1494692B1 Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis |
| 05/02/2007 | EP1492766B1 Improved cc-1065 analog synthesis |
| 05/02/2007 | EP1492546B1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 05/02/2007 | EP1482919B1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes |
| 05/02/2007 | EP1480963B1 Method for producing 3-amidinophenylalanine derivatives |
| 05/02/2007 | EP1471871B1 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 05/02/2007 | EP1470127B1 N, n'-dimethylated n-confused porphyrins |
| 05/02/2007 | EP1458707B1 New Indol-2-one derivatives |
| 05/02/2007 | EP1451197B1 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]-nonane derivatives, preparation and therapeutic use thereof |
| 05/02/2007 | EP1441723B1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 05/02/2007 | EP1418905B1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 05/02/2007 | EP1414824B1 Novel anticonvulsant derivative salts |
| 05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1346058B1 Adenoviral systems and the uses thereof |
| 05/02/2007 | EP1343480B1 Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| 05/02/2007 | EP1341542B1 Indanylderivatives for treating airway diseases |
| 05/02/2007 | EP1330467B1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 05/02/2007 | EP1322608B1 Delta1-pyrrolines used as pesticides |
| 05/02/2007 | EP1322590B1 5-amino-1-pentene-3-ol substituted derivatives |
| 05/02/2007 | EP1313716B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 05/02/2007 | EP1312373B1 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 05/02/2007 | EP1311248B1 Transdermal therapeutic system for treating restless-legs-syndrome |
| 05/02/2007 | EP1282725B1 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR |
| 05/02/2007 | EP1268478B1 Phenyl-substituted imidazopyridines |
| 05/02/2007 | EP1261372B1 Method of treating cancer with anti-neurotrophin agents |
| 05/02/2007 | EP1228052B1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | EP1220830B1 Use of elastase for opening obstructed arteries and veins |
| 05/02/2007 | EP1219708B1 Modulate aptamer and method for detecting target protein by using the same |
| 05/02/2007 | EP1213964B1 Phytochemicals for treatment of mastalgia and endometriosis |
| 05/02/2007 | EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/02/2007 | EP1165097B1 A pharmaceutical composition of complex carbohydrates and their use |
| 05/02/2007 | EP1156821B1 Treatment of infertility |
| 05/02/2007 | EP1144675A4 Pharmacokinetic-based drug design tool and method |
| 05/02/2007 | EP1121115B1 Pufa supplements |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | EP1103255B1 Method of rearing and feeds |
| 05/02/2007 | EP1077069B1 Preventives/remedies for hepatic cirrhosis |
| 05/02/2007 | EP1035840A4 Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| 05/02/2007 | EP1032405A4 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/02/2007 | EP1009846B1 Alphavirus-derived vectors useful as vaccines providing protection against paramyxovirus infection |
| 05/02/2007 | EP0946183B1 Use of pyridazinone or phosphine oxide compounds to treat or prevent cardiac arrhythmia |
| 05/02/2007 | EP0934352B1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption |
| 05/02/2007 | EP0906426B1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 05/02/2007 | EP0869968B1 Growth-hormone secretagogues |
| 05/02/2007 | EP0831827B1 Novel formulations for transdermal delivery of pergolide |
| 05/02/2007 | EP0723579B1 Protease-containing cleaning compositions |
| 05/02/2007 | CN2894699Y Film-coated tablet of norcantharidin |
| 05/02/2007 | CN1957082A Novel galectin 9 modification protein and use thereof |
| 05/02/2007 | CN1956993A Macrolides with antiinflammatory activity |
| 05/02/2007 | CN1956992A Anthracycline derivatives |
| 05/02/2007 | CN1956991A Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 05/02/2007 | CN1956989A Purine derivative |
| 05/02/2007 | CN1956987A Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 05/02/2007 | CN1956986A 6-substituted pyridoindolone derivatives, production method and therapeutic use thereof |
| 05/02/2007 | CN1956984A 1,3,4-oxadiazol-2-ones as PPAR-delta modulators |
| 05/02/2007 | CN1956983A 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| 05/02/2007 | CN1956982A Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton |
| 05/02/2007 | CN1956981A Agent for treating keratoconjunctival trouble |
| 05/02/2007 | CN1956980A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956979A Thiazole derivative |
| 05/02/2007 | CN1956978A [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase |
| 05/02/2007 | CN1956977A Pharmaceutical dosage forms and compositions of 5-HT1a receptor antagonists |
| 05/02/2007 | CN1956976A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956975A Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 05/02/2007 | CN1956971A Novel fused heterocycles and application thereof |
| 05/02/2007 | CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors |
| 05/02/2007 | CN1956968A Aryl glycinamide derivatives and their use as NK1 antagonists and 5-serotonin reuptake inhibithors |